Medicine & Life Sciences

1. Breast Neoplasms 100%
2. Coronavirus 47%
3. Pandemics 40%
4. Neoadjuvant Therapy 33%
5. Drug Therapy 32%
6. Breast Cancer 3 27%
7. Physicians 25%
8. Neoplasms 23%
9. Recurrence 22%
10. AMG 479 19%
11. Lobular Carcinoma 18%
12. STA 9090 17%
13. Survival 17%
14. durvalumab 16%
15. Standard of Care 16%
16. Hormones 16%
17. Paclitaxel 15%
18. Cross-Sectional Studies 15%
19. olaparib 14%
20. Free Association 14%
21. Residual Neoplasm 13%
22. Adjuvant Chemotherapy 13%
23. Anxiety 13%
24. Body Mass Index 13%
25. Insulin 12%
26. Carcinoma, Ductal, Breast 12%
27. Genes 12%
28. Doxorubicin 12%
29. Somatomedins 12%
30. Aromatase Inhibitors 11%
31. Therapeutics 11%
32. Cancer Survivors 11%
33. Mesothelioma 11%
34. Medical Oncology 11%
35. RNA-Seq 11%
36. Biomarkers 11%
37. Progression-Free Survival 10%
38. Progesterone Receptors 10%
39. Bariatric Surgery 10%
40. Phytochemicals 10%
41. Hospital Societies 10%
42. Metformin 10%
43. Tamoxifen 10%
44. Fluorodeoxyglucose F18 9%
45. Transcriptome 9%
46. Ductal Carcinoma 9%
47. Angiotensin-Converting Enzyme Inhibitors 9%
48. Health 9%
49. Growth Hormone 9%
50. Bone Marrow Cells 8%